Patent Application
20220265983
The present invention relates generally to catheters, and in particular to a catheter system with an implantable port for administering anesthetics and other localized pharmacologicals. A port placement method utilizes ultrasound imaging for placement in proximity to patients' nerves and nerve centers.
Various medical procedures involve the administration of pharmacologicals for achieving favorable outcomes. For example, anesthesiology typically involves anesthetizing patients during surgery and other medical and dental procedures. General anesthetics render patients unconscious for limited, predetermined periods of time, during which medical procedures, e.g., surgeries, are performed. Local anesthetics are commonly used for anesthetizing specific areas of patients, e.g., for dental procedures, surgeries performed on extremities, etc.
The field of palliative care involves treating patients who have been diagnosed with serious illnesses. Palliative care objectives include improving patient quality of life and minimizing disruption for caregivers, e.g., medical professionals and family members. Palliative care is a growing field in medicine. Population demographics in the United States, including an aging population, are likely to contribute to more palliative care cases and greater anticipated demand for adequate pain relief. End-of-life patients are often treated by hospice care medical service providers. Patients receiving hospice care often require medications for chronic pain.
Opioids represent a significant class of pain control drugs and are commonly prescribed for and administered to patients dealing with chronic pain, including hospice care patients. However, opioid-based pharmaceuticals have multiple disadvantages. Patient addiction and opioid dependency are significant concerns. Expense and stringent regulatory (e.g., FDA) control are additional factors. Moreover, patients can develop tolerances, which can necessitate switching treatment protocols and increasing required dosages to achieve effective outcomes.
Catheters for administering medications, including anesthetics, via patients' venous circulatory systems are well-known in the art. For example, Luther U.S. Pat. No. 5,403,283 discloses a percutaneous port catheter assembly and method of use. Cal et al. U.S. Pat. No. 5,743,873 discloses methods for using catheter connectors and portals, and methods of assembly.
Anesthetics are generally most effective when administered in proximity to patients' nerves. Relatively recent improvements in ultrasound technology enable healthcare providers to more precisely visualize and locate nerves, as compared to blind catheter placement techniques used previously.
Heretofore there has not been available a catheter system and method with the advantages and features of the present invention.
A catheter system includes an implantable port connected to a catheter. The catheter can be placed in proximity to nerves using ultrasound imaging techniques and equipment. Optimal catheter placement is generally determined by diagnosing patients and identifying areas causing pain or otherwise requiring the application of pharmacologicals. For example, surgical sites contribute to patient pain and discomfort during the healing process. In oncology cases, chemotherapy medications are commonly administered in proximity to tumors. Various medications, including anesthetics and chemotherapy medications, can be injected or pumped into the implantable port. Huber needles are specifically designed for administering medications to the implantable ports.
A medication delivery method according to the present invention includes the steps of placing an implantable port, extending a catheter from the port to an affected area requiring treatment, and cycling the medication administration as necessary to achieve a favorable outcome, such as healing or alleviating pain and discomfort.
As required, detailed aspects of the present invention are disclosed herein, however, it is to be understood that the disclosed aspects are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art how to variously employ the present invention in virtually any appropriately detailed structure.
Certain terminology will be used in the following description for convenience in reference only and will not be limiting. For example, up, down, front, back, right and left refer to the invention as orientated in the view being referred to. The words, “inwardly” and “outwardly” refer to directions toward and away from, respectively, the geometric center of the aspect being described and designated parts thereof. Said terminology will include the words specifically mentioned, derivatives thereof and words of similar meaning.
A catheter system 2 embodying an aspect of the present invention is shown in
A medication dispenser 12 can comprise a syringe 14 connected to tubing 16 terminating at a needle 18. Huber and other suitable needles can be used for injecting medications into the subcutaneous port 4. Various other medication dispensing devices can be used with the catheter system 2 of the present invention. For example, in lieu of a manually-operated syringe 14, a motorized pump can be provided. Moreover, the medication dispenser 12 can be automated with a programmable microprocessor for cycling the operation of a motorized pump to dispense medication at predetermined intervals consistent with a predetermined treatment protocol. Moreover, various medications can be selectively administered, including, without limitation, anesthetics, chemotherapy medications, growth factors, antiseptics, etc.
Medication is administered at 42 and its efficacy is monitored at 44. Complications are monitored at 46 and can include, for example, infection, excessive fluid accumulation, etc. If a modified treatment plan is deemed necessary (“Yes” path from decision box 48), the protocol loops back to the treatment plan step 26. If “No,” the treatment terminates at 50.
The catheter system 2 and method of the present invention can be adapted to accommodate a variety of medical conditions and treatment protocols. For example, antiseptics for infection control and growth factors for promoting reepithelialization can be introduced to a wound site.
It is to be understood that while certain embodiments and/or aspects of the invention have been shown and described, the invention is not limited thereto and encompasses various other embodiments and aspects.
This application is related to and claims priority in U.S. Provisional Patent Application Ser. No. 63/200,204, filed Feb. 21, 2021, which is incorporated herein by reference in its entirety.
| Number | Date | Country | |
|---|---|---|---|
| 63200204 | Feb 2021 | US |
